While TP53 is commonly mutated in many solid tumors in adults [10], many types of cancer including childhood [11] and hematological cancers [12] are frequently TP53-wildtype at diagnosis, and thus, cancer must have escaped p53-dependent tumor suppression by other mechanisms. This evidence concerns the gene TP53 and hematopoietic and lymphoid cell neoplasm.